Page last updated: 2024-09-03

vadimezan and Cancer of Prostate

vadimezan has been researched along with Cancer of Prostate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clingan, P; Dreicer, R; Goel, S; Leach, J; Mainwaring, PN; Pili, R; Rosenthal, MA; Srinivas, S; Van Hazel, G; Wong, S	1
McKeage, MJ	1

Reviews

1 review(s) available for vadimezan and Cancer of Prostate

Article	Year
The potential of DMXAA (ASA404) in combination with docetaxel in advanced prostate cancer. Expert opinion on investigational drugs, 2008, Volume: 17, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Disease-Free Survival; Docetaxel; Humans; Male; Neoplasm Invasiveness; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Xanthones	2008

Trials

1 trial(s) available for vadimezan and Cancer of Prostate

Article	Year
Phase II study on the addition of ASA404 (vadimezan; 5,6-dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, May-15, Volume: 16, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Resistance, Neoplasm; Electrocardiography; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Xanthones	2010

Article

Year

Phase II study on the addition of ASA404 (vadimezan; 5,6-dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, May-15, Volume: 16, Issue:10

Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Resistance, Neoplasm; Electrocardiography; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Xanthones

2010

Other Studies

1 other study(ies) available for vadimezan and Cancer of Prostate

Article	Year
Molecule of the month. Vadimezan. Drug news & perspectives, 2009, Volume: 22, Issue:9 Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Treatment Outcome; Xanthones	2009